购物车
您的购物车当前为空
别名 Mal-Deferoxamine
Mal-Deferoxamine 是 Deferoxamine 的马来酰亚胺功能化衍生物,其中的马来酰胺基团可与含巯基的生物分子发生高度选择性的共价偶联,形成稳定连接,适用于化学生物学与放射性药物工程研究。Mal-Deferoxamine 可高效螯合医用放射性核素,生成放射性核素药物偶联物(RDCs),使 Martinostat hydrochloride 成为诊断探针及放射诊疗一体化试剂开发中的多功能分子骨架。


为众多的药物研发团队赋能,
让新药发现更简单!
Mal-Deferoxamine 是 Deferoxamine 的马来酰亚胺功能化衍生物,其中的马来酰胺基团可与含巯基的生物分子发生高度选择性的共价偶联,形成稳定连接,适用于化学生物学与放射性药物工程研究。Mal-Deferoxamine 可高效螯合医用放射性核素,生成放射性核素药物偶联物(RDCs),使 Martinostat hydrochloride 成为诊断探针及放射诊疗一体化试剂开发中的多功能分子骨架。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 390 | 现货 | |
| 5 mg | ¥ 880 | 现货 | |
| 10 mg | ¥ 1,320 | 现货 | |
| 25 mg | ¥ 2,250 | 现货 | |
| 50 mg | ¥ 3,650 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,480 | 现货 |
| 产品描述 | Mal-Deferoxamine is a maleimide-functionalized derivative of Deferoxamine in which the maleamide group enables highly selective and covalent conjugation with thiol-containing biomolecules, forming stable linkages suited for chemical biology and radiopharmaceutical engineering. Mal-Deferoxamine readily chelates medical radionuclides to generate radionuclide drug conjugates (RDCs), which permit targeted molecular imaging or therapeutic delivery owing to their ability to engage specific biomolecular targets with high affinity, making this compound a versatile scaffold for the development of diagnostic probes and radiotheranostic agents. |
| 别名 | Mal-Deferoxamine |
| 分子量 | 711.8 |
| 分子式 | C32H53N7O11 |
| CAS No. | 1638156-31-6 |
| Smiles | O=C1C=CC(=O)N1CCC(=O)NCCCCCN(O)C(=O)CCC(=O)NCCCCCN(O)C(=O)CCC(=O)NCCCCCN(O)C(=O)C |
| 密度 | no data available |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 65.00 mg/mL (91.32 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
对于不同动物的给药剂量换算,您也可以参考 更多